IL201627A - Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On - Google Patents

Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On

Info

Publication number
IL201627A
IL201627A IL201627A IL20162709A IL201627A IL 201627 A IL201627 A IL 201627A IL 201627 A IL201627 A IL 201627A IL 20162709 A IL20162709 A IL 20162709A IL 201627 A IL201627 A IL 201627A
Authority
IL
Israel
Prior art keywords
methylpyrrolidine
tartrate
methyl
phenyl
propoxy
Prior art date
Application number
IL201627A
Other languages
English (en)
Hebrew (he)
Other versions
IL201627A0 (en
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of IL201627A0 publication Critical patent/IL201627A0/en
Publication of IL201627A publication Critical patent/IL201627A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Catalysts (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL201627A 2007-05-03 2009-10-19 Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On IL201627A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
PCT/US2008/005702 WO2008137087A1 (en) 2007-05-03 2008-05-02 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof

Publications (2)

Publication Number Publication Date
IL201627A0 IL201627A0 (en) 2010-05-31
IL201627A true IL201627A (en) 2014-06-30

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
IL201627A IL201627A (en) 2007-05-03 2009-10-19 Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On

Country Status (14)

Country Link
EP (1) EP2152669A1 (enExample)
JP (1) JP5698887B2 (enExample)
KR (1) KR20100017565A (enExample)
CN (1) CN101679237A (enExample)
AU (1) AU2008248168B2 (enExample)
BR (1) BRPI0810330A2 (enExample)
CA (1) CA2686033A1 (enExample)
EA (1) EA019031B1 (enExample)
IL (1) IL201627A (enExample)
MX (1) MX2009011787A (enExample)
NZ (1) NZ580948A (enExample)
UA (1) UA99913C2 (enExample)
WO (1) WO2008137087A1 (enExample)
ZA (1) ZA200907643B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2492263A1 (en) 2006-07-25 2012-08-29 Cephalon, Inc. Pyridizinone Derivatives
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
CA2712885A1 (en) 2008-01-30 2009-08-06 Cephalon, Inc. Substituted pyridazine derivatives which have histamine h3 antagonist activity
WO2016105529A1 (en) * 2014-12-23 2016-06-30 Cephalon, Inc. Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives
DK3847157T3 (da) * 2018-09-07 2022-08-08 Sanofi Sa Fremgangsmåde til fremstilling af methyl-[6-(2,4-dichlorphenyl)-5-[4-[(3s)-1-(3-fluorpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulen-2-carboxylat] og salt deraf

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
CN100543050C (zh) 2004-03-08 2009-09-23 独立行政法人科学技术振兴机构 高分子担载金属簇组合物
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
ATE383857T1 (de) 2004-06-02 2008-02-15 Hoffmann La Roche Als histamin-3-rezeptorliganden einsetzbare naphthalene-derivate
CN101111480A (zh) 2004-12-01 2008-01-23 万有制药株式会社 取代的吡啶酮衍生物
DE602005026169D1 (de) 2004-12-17 2011-03-10 Janssen Pharmaceutica Nv Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
CN101107231A (zh) 2005-01-21 2008-01-16 先灵公司 用作组胺h3拮抗剂的咪唑和苯并咪唑衍生物
AU2006228690A1 (en) 2005-03-31 2006-10-05 Ucb Pharma S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
EP1943217A1 (en) 2005-10-27 2008-07-16 UCB Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
WO2007094962A2 (en) 2006-02-09 2007-08-23 Athersys, Inc. Pyrazoles for the treatment of obesity and other cns disorders
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
EP2007749A2 (en) 2006-03-13 2008-12-31 Pfizer Products Inc. Tetralines antagonists of the h-3 receptor
WO2008005338A1 (en) 2006-06-29 2008-01-10 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
EP2492263A1 (en) 2006-07-25 2012-08-29 Cephalon, Inc. Pyridizinone Derivatives

Also Published As

Publication number Publication date
MX2009011787A (es) 2009-11-13
AU2008248168B2 (en) 2013-03-21
BRPI0810330A2 (pt) 2014-10-14
ZA200907643B (en) 2014-03-26
IL201627A0 (en) 2010-05-31
CN101679237A (zh) 2010-03-24
EA019031B1 (ru) 2013-12-30
CA2686033A1 (en) 2008-11-13
UA99913C2 (ru) 2012-10-25
EA200971019A1 (ru) 2010-04-30
KR20100017565A (ko) 2010-02-16
JP2010526142A (ja) 2010-07-29
WO2008137087A1 (en) 2008-11-13
NZ580948A (en) 2011-04-29
AU2008248168A1 (en) 2008-11-13
EP2152669A1 (en) 2010-02-17
JP5698887B2 (ja) 2015-04-08

Similar Documents

Publication Publication Date Title
US20100121055A1 (en) Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
JP6491393B2 (ja) ヒストン脱アセチル化酵素６阻害剤としての１，３，４−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物
JP6392888B2 (ja) ヒストン脱アセチル化酵素６阻害剤としての新規化合物およびこれを含む薬剤学的組成物
CN111770918B (zh) Trpc6的抑制剂
AU2006275870B2 (en) Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
CN108718527A (zh) 用于制备4-苯基-5-烷氧羰基-2-噻唑-2-基-1，4-二氢嘧啶-6-基]甲基]-3-氧代-5，6，8，8a-四氢-1H-咪唑并[1，5-a]吡嗪-2-基]-甲酸的方法
IL201627A (en) Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On
EA009903B1 (ru) Бициклические [3.1.0] производные в качестве ингибиторов переносчиков глицина
JP2024512428A (ja) 抗ウイルス化合物
CA2791431A1 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
JP2023533783A (ja) ヒストン脱アセチル化酵素６阻害剤としての新規な構造の化合物およびこれを含む薬剤学的組成物
CA2470236A1 (en) Lactams as tachykinin antagonists
CN113677673B (zh) Trpc6的抑制剂
WO2007102567A1 (ja) 3,4-ジ置換ピロリジン誘導体の製造方法及び製造中間体
AU2007329808A1 (en) 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulators
ES2561834T3 (es) Naftiridonas y quinolonas 7-amino alquilidenil-heterocíclicas
EP1546145A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
JP2010526142A5 (enExample)
KR20230164136A (ko) Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로시클릭 화합물
AU2005252178B2 (en) Histamine H3 receptor agents, preparation and therapeutic uses
ZA200700950B (en) Pyrrole derivatives, their preparation and their therapeutic use
AU2006316609A1 (en) Modulators of the H3 receptor useful for the treatment of disorders related thereto
WO2002089803A1 (fr) Composition d'ionophorese
RU2817736C1 (ru) Новые соединения в качестве ингибитора гистондеацетилазы 6 и фармацевтическая композиция, содержащая их
Yoon‐Miller et al. Suzuki–Miyaura arylations of tetramic acid sulfonates: Evaluation of lactam protection, sulfonate esters, and sterics

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees